BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 30893315)

  • 21. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.
    Ma Y; Katiyar P; Jones LP; Fan S; Zhang Y; Furth PA; Rosen EM
    Mol Endocrinol; 2006 Jan; 20(1):14-34. PubMed ID: 16109739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer.
    Basree MM; Shinde N; Koivisto C; Cuitino M; Kladney R; Zhang J; Stephens J; Palettas M; Zhang A; Kim HK; Acero-Bedoya S; Trimboli A; Stover DG; Ludwig T; Ganju R; Weng D; Shields P; Freudenheim J; Leone GW; Sizemore GM; Majumder S; Ramaswamy B
    Breast Cancer Res; 2019 Jul; 21(1):80. PubMed ID: 31315645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
    Viotto D; Russo F; Anania I; Segatto I; Rampioni Vinciguerra GL; Dall'Acqua A; Bomben R; Perin T; Cusan M; Schiappacassi M; Gerratana L; D'Andrea S; Citron F; Vit F; Musco L; Mattevi MC; Mungo G; Nicoloso MS; Sonego M; Massarut S; Sorio R; Barzan L; Franchin G; Giorda G; Lucia E; Sulfaro S; Giacomarra V; Polesel J; Toffolutti F; Canzonieri V; Puglisi F; Gattei V; Vecchione A; Belletti B; Baldassarre G
    J Pathol; 2021 Feb; 253(2):234-245. PubMed ID: 33140857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
    Feldt M; Bjarnadottir O; Kimbung S; Jirström K; Bendahl PO; Veerla S; Grabau D; Hedenfalk I; Borgquist S
    J Transl Med; 2015 Apr; 13():133. PubMed ID: 25925673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The biology of progesterone receptor in the normal mammary gland and in breast cancer.
    Obr AE; Edwards DP
    Mol Cell Endocrinol; 2012 Jun; 357(1-2):4-17. PubMed ID: 22193050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
    Buser AC; Gass-Handel EK; Wyszomierski SL; Doppler W; Leonhardt SA; Schaack J; Rosen JM; Watkin H; Anderson SM; Edwards DP
    Mol Endocrinol; 2007 Jan; 21(1):106-25. PubMed ID: 16973758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of hyperthyroidism on circulating prolactin and hypothalamic expression of tyrosine hydroxylase, prolactin signaling cascade members and estrogen and progesterone receptors during late pregnancy and lactation in the rat.
    Pennacchio GE; Neira FJ; Soaje M; Jahn GA; Valdez SR
    Mol Cell Endocrinol; 2017 Feb; 442():40-50. PubMed ID: 27919641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CUZD1 is a critical mediator of the JAK/STAT5 signaling pathway that controls mammary gland development during pregnancy.
    Mapes J; Li Q; Kannan A; Anandan L; Laws M; Lydon JP; Bagchi IC; Bagchi MK
    PLoS Genet; 2017 Mar; 13(3):e1006654. PubMed ID: 28278176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling.
    Chiche A; Di-Cicco A; Sesma-Sanz L; Bresson L; de la Grange P; Glukhova MA; Faraldo MM; Deugnier MA
    Breast Cancer Res; 2019 Jan; 21(1):13. PubMed ID: 30683141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of gene expression in the bovine mammary gland by ovarian steroids.
    Connor EE; Meyer MJ; Li RW; Van Amburgh ME; Boisclair YR; Capuco AV
    J Dairy Sci; 2007 Jun; 90 Suppl 1():E55-65. PubMed ID: 17517752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine hormones and local signals during the development of the mouse mammary gland.
    Brisken C; Ataca D
    Wiley Interdiscip Rev Dev Biol; 2015; 4(3):181-95. PubMed ID: 25645332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.
    Shehata M; Teschendorff A; Sharp G; Novcic N; Russell IA; Avril S; Prater M; Eirew P; Caldas C; Watson CJ; Stingl J
    Breast Cancer Res; 2012 Oct; 14(5):R134. PubMed ID: 23088371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary.
    Best SA; Hutt KJ; Fu NY; Vaillant F; Liew SH; Hartley L; Scott CL; Lindeman GJ; Visvader JE
    Development; 2014 Aug; 141(16):3159-64. PubMed ID: 25038044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers.
    Harvell DM; Strecker TE; Tochacek M; Xie B; Pennington KL; McComb RD; Roy SK; Shull JD
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2779-84. PubMed ID: 10688907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.
    Seksenyan A; Kadavallore A; Walts AE; de la Torre B; Berel D; Strom SP; Aliahmad P; Funari VA; Kaye J
    BMC Cancer; 2015 Jan; 15():22. PubMed ID: 25632947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium.
    Rokicki J; Das PM; Giltnane JM; Wansbury O; Rimm DL; Howard BA; Jones FE
    Mol Cancer; 2010 Jun; 9():150. PubMed ID: 20550710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of hormonal prevention of breast cancer.
    Medina D; Sivaraman L; Hilsenbeck SG; Conneely O; Ginger M; Rosen J; Omalle BW
    Ann N Y Acad Sci; 2001 Dec; 952():23-35. PubMed ID: 11795441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In utero and lactational treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs mammary gland differentiation but does not block the response to exogenous estrogen in the postpubertal female rat.
    Lewis BC; Hudgins S; Lewis A; Schorr K; Sommer R; Peterson RE; Flaws JA; Furth PA
    Toxicol Sci; 2001 Jul; 62(1):46-53. PubMed ID: 11399792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.
    Sampayo R; Recouvreux S; Simian M
    Vitam Horm; 2013; 93():185-201. PubMed ID: 23810007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of ATBF1 by progesterone-PR signaling and its functional implication in mammary epithelial cells.
    Li M; Zhao D; Ma G; Zhang B; Fu X; Zhu Z; Fu L; Sun X; Dong JT
    Biochem Biophys Res Commun; 2013 Jan; 430(1):358-63. PubMed ID: 23159610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.